Artal Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-150,000	Closed	-$1.91M	–	124
2017 Q4	$1.91M	Sell	150,000 -50,000	-25%	-$638K	0.03%	61
2017 Q3	$3.12M	Sell	200,000 -50,000	-20%	-$779K	0.05%	52
2017 Q2	$3.51M	Sell	250,000 -50,000	-17%	-$702K	0.06%	52
2017 Q1	$6.6M	Buy	+300,000	New	+$6.6M	0.15%	33